Application of cognitive fusion combined with 12-core systematic transperineal prostate biopsy in daytime operation mode
Objective:To evaluate the safety and efficacy of cognitive fusion combined with 12-core systematic transperineal prostate biopsy in daytime operation mode.Methods:The clinical data of 489 patients who under-went transperineal cognitive fusion prostate biopsy in daytime operation mode in Yantai Yuhuangding Hospital were analyzed retrospectively from June 2019 to August 2022.Prostate cancer detection rate,operation time,hos-pital stay,visual analogue scale,and complications were recorded.Results:Prostate cancer was detected in 261(53.37％)patients and cancer detection rates for clinically significant prostate cancer was 78.93％(206/261).There was no significant difference in the total PCa detection rate between systemic and cognitive fusion biopsy(47.03％vs 44.17％,230 cases vs 216 cases,P=0.135),and more clinically significant prostate cancers were detected by cognitive fusion biopsy(36.61％vs 32.92％,179 cases vs 161 cases,P＜0.001).The average opera-tion time was(8.92±0.98)minutes.The average visual analogue scale was 2.50±1.16(0-6).Complication in-cidence was 10.02％,including urinary retention(5 patients),hematuria(35 patients)and fever(9 patients).No patients had sepsis and all complications were improved after treatment.Conclusion:Cognitive fusion combined with 12-core systematic transperineal prostate biopsy in daytime operation mode was safe and effective.
NETL
NSTL
万方数据
